Just wanted to follow up on my previous post
I don't want go on about POTENTIAL we have sacks full of $$$$$ in POTENTIAL moving forwards
I would like to address present day and where i believe the company is falling down
For all that has been achieved this last 12 months we are just not getting the traction we should be in the market
Yes you will have folks come on here and tell you it will happen be patient LOL and yes it will happen at some stage yes it will, But i am not talking about this, what i am talking about is extracting maximum value from the markets for each and every milestone achieved, who is to say when we hit $1 we should really be sat @$2 because we are not reaching our full POTENTIAL lol that word again
ok so to move on
They say
A picture paints a thousand words
So lets take a look and see what the following pictures have to say
COLOUR CODES
Light Blue Broker reports
Dark Blue Conferences and market updates by MD
Yellow Price sensitive Announcements
Green Inmvestment seminars
Ok
So what dos the above tell you at a glance
WOW
PROMINANCE YELLOW PRICE SENSITIVE ANN 22 in fact BIG TICK PASS
LACKING GREEN INVESTMENT SEMINARS only 5 BIG X FAIL
So lets move on
Yellow Price Sensitive Ann
Pretty Random really except to say plenty of price sensitive news last year some in the highs some in the lows ( feel free to comment )
So to move on
Conferences and Updates
Again mixed bag Some in the highs some in the lows
So to move on, this is where it starts to get interesting
Investment roadshows 5 in total
Well 5 investment roadshows has to be pretty Pi$$ poor when you look at all the price sensitive announcements
Plus every one was sold into barring one Not very impressive at all at all and one has to question how convincing is our MD is in these seminars if this is the market reaction
So to move on
Broker reports 15 in total
15 reports very impressive but have we extracted maximum value
Oh dear i think not
So lets take a look again very interesting see below
Now this picture above is the one that really tells the story, which i have tried to fill in, inside the chart, Am hoping for a partner but to me its looking like a CR
So looking at the above i think its quite clear that we are just not getting market penetration for all that has been achieved, and you don't have to take my word for that, just read the latest reports
I also believe that appointing Charmaine to the Chair of the board once again was a
HUGE, A HUGE MISTAKE.
They offered her the wrong position IMHO she should have been offered the position of CEO
This was a perfect opportunity to change the FACE of ANP along with the other reshuffle and maybe the possibility of a name change to freshen up the whole company
Now all the above is just IMHO i am no scientist, doctor, or professor, just a simple dad grandad and tradie, so obviously have no idea what i am going on about
But i do believe we need attention to market detail,
i hope you enjoy, if not that's fine its a contribution however you see it
SEE HOW WE GO
- Forums
- ASX - By Stock
- PER
- CD49d promotes disease progression in chronic lymphocytic leukemia
CD49d promotes disease progression in chronic lymphocytic leukemia, page-11
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.004(5.26%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
7.9¢ | 8.0¢ | 7.7¢ | $35.48K | 451.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12500 | 7.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 198147 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1471 | 0.077 |
1 | 69866 | 0.074 |
1 | 75000 | 0.073 |
2 | 15000 | 0.070 |
1 | 100000 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 198147 | 2 |
0.081 | 198015 | 2 |
0.082 | 75174 | 2 |
0.083 | 93000 | 1 |
0.084 | 200300 | 2 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |